Validation using item response theory, and assessment of sensitivity to change of the Hypoglycemia Awareness Questionnaire in patients with type 2 diabetes treated with insulin
Journal of Diabetes Investigation · 2025
DOI: 10.1111/jdi.14406 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Julieth Patricia García-Lugo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Universitaria de Ciencias de la Salud (FUCS), Bogotá, Colombia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemia, Insulin, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundación Universitaria de Ciencias de la Salud.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims/Introduction It is important to develop valid tools to evaluate hypoglycemia perception such as the Hypoglycemia Awareness Questionnaire (HypoA‐Q) in patients with Type 2 Diabetes (T2D). The aim of the study is to validate the HypoA‐Q in patients with T2D treated with insulin using item response theory. Materials and Methods Individuals with T2D treated with insulin were included by non‐random convenience sampling. A partial credit model was used for validation using item response theory, infit, and outfit statistics were calculated, person‐item map and item characteristic curves were plotted, and differential item functioning was assessed.
Results
The study included 502 participants, the mean age at diagnosis of diabetes was 47.8 ± 13.9 years, the median time with the diagnosis was 15 years (IQR: 9–22), and the mean HbA1c 71 ± 27.3 mmol/mL (8.6 ± 2.5%), 48.6% had Glomerular Filtration Rate >60 mL/min/min 2 . Item fit was found with items covering the full range of the construct of the participant population, although response options could be simplified. The person‐item map showed that the scale covers a wide range of the construct and that the scale has items to measure these different levels. Item bias was not evident when comparing subgroups by age, sex and treatment.
Conclusions
The HypoA‐Q is a valid measure for assessing hypoglycemia awareness in insulin‐treated T2D patients because it has items that fit the measurement process, measures a wide range of awareness, and is free of biases related to gender, age, treatment, and duration of diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fundación Universitaria de Ciencias de la Salud (FUCS), Bogotá, Colombia.
- School of Nursing, Fundación Universitaria de Ciencias de la Salud (FUCS), Bogotá, Colombia.
- Endocrinology Unit, San Ignacio Hospital, Pontificia Universidad Javeriana, Bogotá, Colombia.
ORCID-Profile: Diana Cristina Henao-Carrillo
Förderung
- Fundación Universitaria de Ciencias de la Salud
Zitieren
APA
García-Lugo, J. P., Carrillo Algarra, A. J., Sierra-Matamoros, F. A., Hernández-Zambrano, S. M., & Henao-Carrillo, D. C. (2025). Validation using item response theory, and assessment of sensitivity to change of the Hypoglycemia Awareness Questionnaire in patients with type 2 diabetes treated with insulin. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14406
Vancouver
García-Lugo JP, Carrillo Algarra AJ, Sierra-Matamoros FA, Hernández-Zambrano SM, Henao-Carrillo DC. Validation using item response theory, and assessment of sensitivity to change of the Hypoglycemia Awareness Questionnaire in patients with type 2 diabetes treated with insulin. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.14406
BibTeX
@article{GarcaLugo2025,
author = {García-Lugo, Julieth Patricia and Carrillo Algarra, Ana Julia and Sierra-Matamoros, Fabio Alexander and Hernández-Zambrano, Sandra Milena and Henao-Carrillo, Diana Cristina},
title = {Validation using item response theory, and assessment of sensitivity to change of the Hypoglycemia Awareness Questionnaire in patients with type 2 diabetes treated with insulin},
journal = {Journal of Diabetes Investigation},
year = {2025},
doi = {10.1111/jdi.14406}
}
EUVIMED